InsiderTrades

Form 4 for FTDR Frontdoor, Inc.

Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-07 · accession 0000950170-25-106572 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-11 2025-08-07 FTDR Fiarman Jeffrey SVP, CLO, Sec M - OptEx $28.39 +129.7K 164.3K +374% +$3.68M
D 2025-08-11 2025-08-07 FTDR Fiarman Jeffrey SVP, CLO, Sec S - Sale+OE $56.15 -129.7K 34.6K -79% -$7.28M
DM 2025-08-11 2025-08-07 FTDR Fiarman Jeffrey SVP, CLO, Sec M - OptEx $0.00 -129.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-07 M A 15,762 $34.48 50,408 D — — (F1) Includes 284 aggregate shares of the Company's common stock acquired under the Frontdoor, Inc. 2019 Employee Stock Purchase Plan on June 30, 2025.
2 Common Common Stock 2025-08-07 M A 23,488 $24.74 92,195 D — —
3 Common Common Stock 2025-08-07 M A 18,299 $35.56 68,707 D — —
4 Common Common Stock 2025-08-07 M A 72,124 $26.42 164,319 D — —
5 Common Common Stock 2025-08-07 S D 129,673 $56.15 34,646 D — — (F2) This transaction was executed in multiple trades at prices ranging from $55.94 to 57.04, inclusive. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
6 Derivative Employee Stock Options (Right to Buy) 2025-08-07 M D 23,488 $0.00 0 D $24.74 · — to 2032-06-01 23,488 Common Stock (F5) Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on June 1, 2022. The performance criteria vested in three performance tranches, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $35.00, $40.00 and $45.00, respectively, over any 20 consecutive trading-day period. The service condition was satisfied on June 1, 2023. The performance-vesting criteria was met on August 18, 2023, August 9, 2024 and September 23, 2024 for the first, second and third tranches of the award, respectively, as certified by the Compensation Committee of the Company's Board of Directors.
7 Derivative Employee Stock Options (Right to Buy) 2025-08-07 M D 15,762 $0.00 0 D $34.48 · — to 2029-03-29 15,762 Common Stock (F3) Non-qualified stock options granted on March 29, 2019 vested 25% on March 29, 2020, and thereafter vested 6.25% quarterly over the next three years on the quarterly anniversary of the grant date, such that all shares vested on March 29, 2023, subject to continued employment with the Company.
8 Derivative Employee Stock Options (Right to Buy) 2025-08-07 M D 18,299 $0.00 0 D $35.56 · — to 2030-03-30 18,299 Common Stock (F4) Non-qualified stock options granted on March 30, 2020 vested 25% on March 30, 2021, and thereafter vested 6.25% quarterly over the next three years on the quarterly anniversary of the grant date, such that all shares vested on March 30, 2024, subject to continued employment with the Company.
9 Derivative Employee Stock Options (Right to Buy) 2025-08-07 M D 72,124 $0.00 0 D $26.42 · — to 2033-03-27 72,124 Common Stock (F6) Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on March 27, 2023. The performance criteria vested in three performance tranches, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $32.23, $35.14 and $38.31, respectively, over any 20 consecutive trading-day period. The service condition was satisfied on March 27, 2024. The performance-vesting criteria was met on July 20, 2023, August 8, 2023 and August 2, 2024 for the first, second and third tranches of the award, respectively, as certified by the Compensation Committee of the Company's Board of Directors.